“…In the brain, the proper functioning of the eNOS/NO system accounts for the microenvironment homeostasis needed for normal operative neuron and glial cells; NO produced by eNOS plays a key role in hemodynamics by regulating blood flow and blood pressure through the control of vasodilation and vascular resistance, platelet adhesion and aggregation, and leukocyte-to-endothelium interaction. A number of pathological settings disturb such nitrergic control, resulting in endothelial and vascular dysfunction (Iadecola, 1997; see Atochin and Huang, 2010), the incapacity of normal synthesis of eNOS derived-NO has been associated with enhanced production of reactive oxygen species, disruption of endogenous control of eNOs inhibitors, effect on BBB and NVu functioning and worsening of pathological conditions (Toda et al, 2010;F€ orstermann and Münzel, 2006;Beauchesne et al, 2009;F€ orstermann and Li, 2011;Santhanam et al, 2012). eNOS dimerization is a mandatory condition for the calciumdependent catalytic activity of the enzyme (Persechini et al, 2013), and eNOS uncoupling resulting from increased monomerization, leads to a decline in NO bioavailability and enhanced production of superoxide (Domenico, 2004;Masano et al, 2008;Münzel et al, 2005;Sabri et al, 2011;Yang et al, 2009).…”